PULSE BIOSCIENCES INC (PLSE:NASDAQ)
$18.92 0.25 (1.339%)
Analysed PULSE BIOSCIENCES INC (PLSE:NASDAQ) News Sources
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study
13-04-2026
yahoo.com
Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy?
12-04-2026
yahoo.com
Pulse Biosciences hires Liane Teplitsky as COO
10-04-2026
medtechdive.com
Pulse Biosciences Strengthens Executive Leadership Team
09-04-2026
yahoo.com
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
07-04-2026
yahoo.com
Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
02-04-2026
yahoo.com
PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data
26-03-2026
yahoo.com
Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study
21-03-2026
marketbeat.com
Truffle Capital Unveils the First Edition of the Truffle MedTech 10
18-03-2026
yahoo.com
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
17-03-2026
yahoo.com
What is the current price of PULSE BIOSCIENCES INC (PLSE:NASDAQ)?
The current price of PULSE BIOSCIENCES INC (PLSE:NASDAQ) is $18.92.
PULSE BIOSCIENCES INC (PLSE:NASDAQ) absolute price change since previous trading day?
The absolute price change of PULSE BIOSCIENCES INC (PLSE:NASDAQ) since the previous trading day is $0.25.
PULSE BIOSCIENCES INC (PLSE:NASDAQ) percentage price change since previous trading day?
The percentage price change of PULSE BIOSCIENCES INC (PLSE:NASDAQ) since the previous trading day is 1.339%.
What is the most recent average sentiment score for PULSE BIOSCIENCES INC (PLSE:NASDAQ)?
The most recent average sentiment score for PULSE BIOSCIENCES INC (PLSE:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PULSE BIOSCIENCES INC (PLSE:NASDAQ)?
The most recent sentiment for PULSE BIOSCIENCES INC (PLSE:NASDAQ) is .
SEC-8K** Filing Available For PULSE BIOSCIENCES INC (PLSE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.